INVITATION TO 9^TH WORLD CANCER CONGRESS - 2025

Arjyopa Healthcare welcomes you to attend the 9^th World Cancer Congress - 2025 during November 20^th - 21^st, 2025 at JNU Convention Centre, JNU Campus, New Delhi, India. We cordially invite all the participants interested in sharing their knowledge and research in the arena of Oncology and Cancer Research. As a host we feel excited that our past 8^th Editions of WCC has able to create impact in people life and which resulted in fruitful collaborations and rewarding experiences for the researchers and speakers. We are also happy that WCC Series has helped them enhance their work practice and impact on their research.

The WCC is a global platform for the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances in cancer science and medicine. From population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy. The WCC-2025 Conference aims to offer global forum for experts, researchers, and participants to discuss latest research in Cancer and Oncology.

The aim and goal of this year summit is to bridge basic and clinical aspects of the genesis, progression, prognosis, prevention, and treatment of cancer. The summit is focused upon disease management, prevention, strategies for early diagnosis, and specific classes of therapeutic agents, results of a clinical trial, an emerging interventional technique, supportive care, and rehabilitation/reconstruction. The conference will provide an ideal platform for knowledge transfer, B2B networking and collaborations along with a delightful experience of a scientific meeting combined with social evenings which will set a perfect backdrop for The 9^th World Cancer Congress-2025.

We look forward to the honor of welcoming you at New Delhi, India during the conference week

Dear Colleague,

On behalf of the Organizing Committee, I am delighted to INVITE you to attend the “9^th World Cancer Congress - 2025”, which will take place in New Delhi-The Capital City of India from 20^th – 21^st November, 2025.

The summit will be organised around the theme of “Novel Discoveries in Cancer Research & Treatment”. It will bring together leading experts from around the world to share the latest advances and best practices in cancer care. The summit will cover a wide range of topics, including cancer screening and prevention, early onset adult cancers, cellular therapies and novel systemic therapies, palliative care and surgical and radiation oncology updates etc.

This event will be an important meeting point to inspire and connect leaders, decision makers, doctors, scientists, technologists, public servants and academics to enhance awareness, quality and safety practices to improve the lives of patients with cancer around the world. The conference will provide the ideal forum to discuss the latest findings and to improve the outcomes for patients with cancer, which is still one of the biggest challenges of the 21^st century. I wish you all a productive and successful conference and look forward to seeing the results of your debates, discussions and knowledge sharing put into practice.

We hope to see you during the conference week at the capital city of India.

Authors are invited to submit abstract(s) using the submission form on this page. Abstracts should contain sufficient detail on the techniques used and the results, which will be shown. You will receive a confirmation when the abstract has been received. Please contact the conference secretariat if you did not receive confirmation within 5 working days. Submission implies the intent of at least one author to register, attend the symposium and present the paper orally or in poster format. Contributions will only be finally accepted after registration and payment of the conference fee. The abstract will be reviewed, and you will be notified of acceptance.

• The entire body of the abstract, excluding tables, must not exceed 250 words. Spaces are not included in this number. Title, authors’ names, affiliations, figures, and tables are not included in the character count.
• The abstract may be structured (i.e., abstracts divided into sections using terms such as Introduction, Methods, Results, Conclusions, etc.) or unstructured.
• Do not use bold type or underline formatting. Italic type is acceptable.
• Text may be in multiple paragraphs.
• Any references should be noted as citations within the text and not as footnotes at the end

1^st Phase Abstract Submission will closes: 15^th November, 2024

Early Bird Registration Closes: 27^th July, 2024